Literature DB >> 4161102

Collagenolytic activity of the skin associated with neuromuscular diseases including amyotrophic lateral sclerosis.

H M Fullmer, W A Gibson, G Lazarus, A C Stam.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4161102     DOI: 10.1016/s0140-6736(66)90116-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  A neutral collagenase from human gastric mucosa.

Authors:  D E Woolley; J S Tucker; G Green; J M Evanson
Journal:  Biochem J       Date:  1976-01-01       Impact factor: 3.857

2.  Purification, characterization and inhibition of human skin collagenase.

Authors:  D E Woolley; R W Glanville; D R Roberts; J M Evanson
Journal:  Biochem J       Date:  1978-02-01       Impact factor: 3.857

3.  The presence of collagenolytic cathepsin in uveal lysosomes of bovine eye.

Authors:  S Hayasaka; I Hayasaka
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-04-07

Review 4.  Role of granulocyte collagenase in collagen degradation.

Authors:  G S Lazarus; J R Daniels; J Lian; M C Burleigh
Journal:  Am J Pathol       Date:  1972-09       Impact factor: 4.307

5.  The further purification and characterization of mouse bone collagenase.

Authors:  S Sakamoto; P Goldhaber; M J Glimcher
Journal:  Calcif Tissue Res       Date:  1972

6.  Degradation of collagen by a human granulocyte collagenolytic system.

Authors:  G S Lazarus; J R Daniels; R S Brown; H A Bladen; H M Fullmer
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

Review 7.  Prospects for the pharmacotherapy of amyotrophic lateral sclerosis : old strategies and new paradigms for the third millennium.

Authors:  Barry W Festoff; Zhiming Suo; Bruce A Citron
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

8.  Studies on collagenase from rheumatoid synovium in tissue culture.

Authors:  J M Evanson; J J Jeffrey; S M Krane
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.